MS
Laurus Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ARV Portfolio (e.g., Dolutegravir, Tenofovir) | HIV/AIDS | Commercial |
| Oncology APIs (e.g., Sorafenib, Lenalidomide) | Various Cancers | Commercial/Filed |
| Cardiovascular APIs (e.g., Valsartan, Atorvastatin) | Hypertension, High Cholesterol | Commercial |
| Biosimilars Pipeline | Oncology, Autoimmune Diseases | Development |
| CDMO Projects | Client-specific | Development to Commercial |
Leadership Team at Laurus Labs
DS
Dr. Satyanarayana Chava
Founder & Chief Executive Officer
VV
V. V. Ravi Kumar
Executive Director & Chief Financial Officer
DR
Dr. Rajendra Prasad
Chief Operating Officer (API Business)
DN
Dr. N. Satish Kumar
President, Formulations
CV
Chava Venkata Satyanarayana Reddy
Whole-time Director
DM
Dr. M. M. Murthy
Senior Vice President, Research & Development
SR
S. R. Rao
Independent Director
DB
Dr. B. N. Suresh
Independent Director
D(
Dr. (Mrs.) Nirmaljeet Kaur
Independent Director
SK
Sanjay K. Jain
Company Secretary & Compliance Officer